A new method of wound treatment: targeted therapy of skin wounds with reactive oxygen species-responsive nanoparticles containing SDF-1α

Tao Tang,1,* Hao Jiang,1,* Yuan Yu,2,* Fang He,1 Shi-zhao Ji,1 Ying-ying Liu,1 Zhong-shan Wang,1 Shi-chu Xiao,1 Cui Tang,3 Guang-Yi Wang,1 Zhao-Fan Xia1 1Department of Burn Surgery, The Second Military Medical University Affiliated Changhai Hospital, 2Department of Pharmaceutics, School of Pharmacy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tang T, Jiang H, Yu Y, He F, Ji SZ, Liu YY, Wang ZS, Xiao SC, Tang C, Wang GY, Xia ZF
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/ae7a602fe39148f1afa395bc83c1bf21
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ae7a602fe39148f1afa395bc83c1bf21
record_format dspace
spelling oai:doaj.org-article:ae7a602fe39148f1afa395bc83c1bf212021-12-02T02:31:35ZA new method of wound treatment: targeted therapy of skin wounds with reactive oxygen species-responsive nanoparticles containing SDF-1α1178-2013https://doaj.org/article/ae7a602fe39148f1afa395bc83c1bf212015-10-01T00:00:00Zhttps://www.dovepress.com/a-new-method-of-wound-treatment-targeted-therapy-of-skin-wounds-with-r-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Tao Tang,1,* Hao Jiang,1,* Yuan Yu,2,* Fang He,1 Shi-zhao Ji,1 Ying-ying Liu,1 Zhong-shan Wang,1 Shi-chu Xiao,1 Cui Tang,3 Guang-Yi Wang,1 Zhao-Fan Xia1 1Department of Burn Surgery, The Second Military Medical University Affiliated Changhai Hospital, 2Department of Pharmaceutics, School of Pharmacy, The Second Military Medical University, 3State Key Laboratory of Genetic Engineering, Department of Pharmaceutical Sciences, School of Life Sciences, Fudan University, Shanghai, People’s Republic of China *These authors contributed equally to this work Objective: To accelerate wound healing through promoting vascularization by using reactive oxygen species (ROS)-responsive nanoparticles loaded with stromal cell-derived factor-1α (SDF-1α).Methods: The ROS-reactive nanomaterial poly-(1,4-phenyleneacetone dimethylene thioketal) was synthesized, and its physical and chemical properties were characterized. ROS-responsive nanoparticles containing SDF-1α were prepared through a multiple emulsion solvent evaporation method. The loading capacity, stability, activity of the encapsulated protein, toxicity, and in vivo distribution of these nanoparticles were determined. These nanoparticles were administered by intravenous infusion to mice with full-thickness skin defects to study their effects on the directed chemotaxis of bone marrow mesenchymal stem cells, wound vascularization, and wound healing.Results: The synthesized ROS-reactive organic polymer poly-(1,4-phenyleneacetone dimethylene thioketal) possessed a molecular weight of approximately 11.5 kDa with a dispersity of 1.97. ROS-responsive nanoparticles containing SDF-1α were prepared with an average diameter of 110 nm and a drug loading capacity of 1.8%. The encapsulation process showed minimal effects on the activity of SDF-1α, and it could be effectively released from the nanoparticles in the presence of ROS. Encapsulated SDF-1α could exist for a long time in blood. In mice with full-thickness skin defects, SDF-1α was effectively released and targeted to the wounds, thus promoting the chemotaxis of bone marrow mesenchymal stem cells toward the wound and its periphery, inducing wound vascularization, and accelerating wound healing. Keywords: reactive oxygen species, stromal cell-derived factor-1α, bone marrow mesenchymal stem cells, wound healingTang TJiang HYu YHe FJi SZLiu YYWang ZSXiao SCTang CWang GYXia ZFDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2015, Iss default, Pp 6571-6585 (2015)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Tang T
Jiang H
Yu Y
He F
Ji SZ
Liu YY
Wang ZS
Xiao SC
Tang C
Wang GY
Xia ZF
A new method of wound treatment: targeted therapy of skin wounds with reactive oxygen species-responsive nanoparticles containing SDF-1α
description Tao Tang,1,* Hao Jiang,1,* Yuan Yu,2,* Fang He,1 Shi-zhao Ji,1 Ying-ying Liu,1 Zhong-shan Wang,1 Shi-chu Xiao,1 Cui Tang,3 Guang-Yi Wang,1 Zhao-Fan Xia1 1Department of Burn Surgery, The Second Military Medical University Affiliated Changhai Hospital, 2Department of Pharmaceutics, School of Pharmacy, The Second Military Medical University, 3State Key Laboratory of Genetic Engineering, Department of Pharmaceutical Sciences, School of Life Sciences, Fudan University, Shanghai, People’s Republic of China *These authors contributed equally to this work Objective: To accelerate wound healing through promoting vascularization by using reactive oxygen species (ROS)-responsive nanoparticles loaded with stromal cell-derived factor-1α (SDF-1α).Methods: The ROS-reactive nanomaterial poly-(1,4-phenyleneacetone dimethylene thioketal) was synthesized, and its physical and chemical properties were characterized. ROS-responsive nanoparticles containing SDF-1α were prepared through a multiple emulsion solvent evaporation method. The loading capacity, stability, activity of the encapsulated protein, toxicity, and in vivo distribution of these nanoparticles were determined. These nanoparticles were administered by intravenous infusion to mice with full-thickness skin defects to study their effects on the directed chemotaxis of bone marrow mesenchymal stem cells, wound vascularization, and wound healing.Results: The synthesized ROS-reactive organic polymer poly-(1,4-phenyleneacetone dimethylene thioketal) possessed a molecular weight of approximately 11.5 kDa with a dispersity of 1.97. ROS-responsive nanoparticles containing SDF-1α were prepared with an average diameter of 110 nm and a drug loading capacity of 1.8%. The encapsulation process showed minimal effects on the activity of SDF-1α, and it could be effectively released from the nanoparticles in the presence of ROS. Encapsulated SDF-1α could exist for a long time in blood. In mice with full-thickness skin defects, SDF-1α was effectively released and targeted to the wounds, thus promoting the chemotaxis of bone marrow mesenchymal stem cells toward the wound and its periphery, inducing wound vascularization, and accelerating wound healing. Keywords: reactive oxygen species, stromal cell-derived factor-1α, bone marrow mesenchymal stem cells, wound healing
format article
author Tang T
Jiang H
Yu Y
He F
Ji SZ
Liu YY
Wang ZS
Xiao SC
Tang C
Wang GY
Xia ZF
author_facet Tang T
Jiang H
Yu Y
He F
Ji SZ
Liu YY
Wang ZS
Xiao SC
Tang C
Wang GY
Xia ZF
author_sort Tang T
title A new method of wound treatment: targeted therapy of skin wounds with reactive oxygen species-responsive nanoparticles containing SDF-1α
title_short A new method of wound treatment: targeted therapy of skin wounds with reactive oxygen species-responsive nanoparticles containing SDF-1α
title_full A new method of wound treatment: targeted therapy of skin wounds with reactive oxygen species-responsive nanoparticles containing SDF-1α
title_fullStr A new method of wound treatment: targeted therapy of skin wounds with reactive oxygen species-responsive nanoparticles containing SDF-1α
title_full_unstemmed A new method of wound treatment: targeted therapy of skin wounds with reactive oxygen species-responsive nanoparticles containing SDF-1α
title_sort new method of wound treatment: targeted therapy of skin wounds with reactive oxygen species-responsive nanoparticles containing sdf-1α
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/ae7a602fe39148f1afa395bc83c1bf21
work_keys_str_mv AT tangt anewmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT jiangh anewmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT yuy anewmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT hef anewmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT jisz anewmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT liuyy anewmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT wangzs anewmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT xiaosc anewmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT tangc anewmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT wanggy anewmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT xiazf anewmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT tangt newmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT jiangh newmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT yuy newmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT hef newmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT jisz newmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT liuyy newmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT wangzs newmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT xiaosc newmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT tangc newmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT wanggy newmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
AT xiazf newmethodofwoundtreatmenttargetedtherapyofskinwoundswithreactiveoxygenspeciesresponsivenanoparticlescontainingsdf1alpha
_version_ 1718402431666094080